研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

Cavomycins A-C,来自环节动物相关链霉菌的线性低聚物缩酚酸肽。

Cavomycins A-C, Linear Oligomer Depsipeptides from an Annelid-Associated Streptomyces cavourensis.

发表日期:2024 Mar 04
作者: Weihong Wang, JunI Lee, Eun Roh, Gauri Shetye, Jin Cao, James McAlpine, Guido Pauli, Scott Franzblau, Thi Hanh Nguyen Vu, Ngoc Tung Quach, Eunseok Oh, Kyu-Hyung Park, Chanyoon Park, Youbin Cho, Hyeseon Jang, SongJoo Han, Hiyoung Kim, Sanghyun Cho, Quyet-Tien Phi, Heonjoong Kang
来源: JOURNAL OF NATURAL PRODUCTS

摘要:

从 Streptomyces cavourensis(一种与环节动物 Paraleonnates uschakovi 相关的肠道细菌)中鉴定出三种独特的线性寡聚缩酚酸肽,命名为 Cavomycins A-C (1-3)。这些缩酚肽的结构是通过光谱方法和化学衍生技术相结合确定的,包括甲醇分解、改进的Mosher方法、先进的Marfey方法和苯基甘氨酸甲酯衍生化。化合物1-3中独特的二肽基残基排列表明它们不是缬氨霉素的降解产物。化合物2及其甲基化衍生物2a对PANC-1胰腺癌细胞表现出抗增殖活性,IC50值分别为1.2和1.7 μM。
Three unique linear oligomeric depsipeptides, designated as cavomycins A-C (1-3), were identified from Streptomyces cavourensis, a gut bacterium associated with the annelid Paraleonnates uschakovi. The structures of these depsipeptides were determined through a combination of spectroscopic methods and chemical derivatization techniques, including methanolysis, the modified Mosher's method, advanced Marfey's methods, and phenylglycine methyl ester derivatization. The unique dipeptidyl residue arrangements in compounds 1-3 indicate that they are not degradation products of valinomycin. Compound 2 and its methylation derivative 2a exhibited antiproliferative activity against PANC-1 pancreatic cancer cells with IC50 values of 1.2 and 1.7 μM, respectively.